Clinical Trials
15 trialsNCT05101213 2026-04-16
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04013802 2025-08-08
TETRAVI
Baylor College of Medicine
Phase 1 Recruiting
NCT06926894 2025-07-31
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Columbia University
Phase 1 Recruiting
NCT03916510 2025-02-06
CEDAR
University of Oxford
Phase 1 Completed
NCT05183490 2024-12-30
R-MVST Cells for Treatment of Viral Infections
Columbia University
Phase 1 Recruiting
NCT06585527 2024-10-31
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Beijing Neurosurgical Institute
Phase 1 Recruiting
NCT02555397 2024-10-10
Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Henry Ford Health System
Phase 1 Completed
NCT03072134 2023-01-20
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
Northwestern University
Phase 1 Completed
NCT04374240 2021-11-03
AdUP
University of Birmingham
Phase 1 Completed
NCT01535885 2021-10-25
ACE
Medical College of Wisconsin
Phase 1 Completed
NCT02894944 2019-09-12
Theragene
Seoul National University Hospital
Phase 1 Completed
NCT03029871 2019-08-13
NSCLC
Henry Ford Health System
Phase 1 Withdrawn
NCT01864759 2017-08-29
Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Institut Català d'Oncologia
Phase 1 Completed
NCT01070797 2014-09-04
VIRAGE
Baylor College of Medicine
Phase 1 Completed
NCT00262327 2006-06-20
Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor
Sun Yat-sen University
Phase 1 Unknown